|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 66.91M 76.53M 61.73M 56.74M 108M 7.36B 109M 737M 289M 3.6B 287M 281M 12.41B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 66.91M 76.53M 61.73M 56.74M 108M 7.36B 109M 737M 289M 3.6B 287M 281M 12.41B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 76.53M | |
| +2.34% | -1.89% | +51.63% | +15.16% | 305B | |
| -0.59% | -0.32% | +25.98% | -6.49% | 69.67B | |
| +1.03% | -5.66% | +33.96% | +98.38% | 8.99B | |
| +0.23% | -1.07% | +6.05% | -1.03% | 8.52B | |
| -3.81% | +8.29% | +14.34% | +32.17% | 4.17B | |
| +4.83% | -4.75% | -20.93% | +2.22% | 4.11B | |
| +4.20% | +0.58% | -38.39% | +22.65% | 3.48B | |
| +2.29% | -5.37% | +42.44% | +58.94% | 2.77B | |
| +4.15% | +8.99% | +15.78% | -15.61% | 2.28B | |
| Average | +1.23% | -0.84% | +14.54% | +22.93% | 45.48B | |
| Weighted average by Cap. | +0.47% | -4.72% | +43.79% | +13.20% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
